Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W R McCabe

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Clinical Obstetrics and Gynecology|June 1, 1979
Adult bacteremia caused by gram-negative bacilliD E Craven, B E Kreger, W R McCabe
Infection and Immunity|March 1, 1987
M proteins of group G streptococci isolated from bacteremic human infectionsA L Bisno, D E Craven, W R McCabe
Medicine|November 1, 1990
Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literatureT W Barber, D E Craven, W R McCabe
The American Journal of Medicine|May 1, 1987
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complexD J Witt, D E Craven, W R McCabe
The American Journal of Medicine|March 1, 1980
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patientsB E Kreger, D E Craven, W R McCabe
The New England Journal of Medicine|June 14, 1973
Limitations of the usefulness of the Limulus assay for endotoxinR J Stumacher, M J Kovnat, W R McCabe
The Journal of Infectious Diseases|January 1, 1975
The relation of K-antigen to virulence of Escherichia coliW R McCabe, P C Carling, S Bruins, et al.
The Journal of Infectious Diseases|August 1, 1988
Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutantW R McCabe, A DeMaria, H Berberich, et al.
The Journal of Infectious Diseases|August 1, 1988
Immunization with rough mutants of Salmonella minnesota: initial studies in human subjectsA DeMaria, M A Johns, H Berberich, et al.
Infection|January 1, 1980
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteriaA DeMaria, S Alvarez, J O Klein, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Clinical Obstetrics and Gynecology|June 1, 1979
Adult bacteremia caused by gram-negative bacilliD E Craven, B E Kreger, W R McCabe
Infection and Immunity|March 1, 1987
M proteins of group G streptococci isolated from bacteremic human infectionsA L Bisno, D E Craven, W R McCabe
Medicine|November 1, 1990
Bacteremia due to Mycobacterium tuberculosis in patients with human immunodeficiency virus infection. A report of 9 cases and a review of the literatureT W Barber, D E Craven, W R McCabe
The American Journal of Medicine|May 1, 1987
Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS-related complexD J Witt, D E Craven, W R McCabe
The American Journal of Medicine|March 1, 1980
Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patientsB E Kreger, D E Craven, W R McCabe
The New England Journal of Medicine|June 14, 1973
Limitations of the usefulness of the Limulus assay for endotoxinR J Stumacher, M J Kovnat, W R McCabe
The Journal of Infectious Diseases|January 1, 1975
The relation of K-antigen to virulence of Escherichia coliW R McCabe, P C Carling, S Bruins, et al.
The Journal of Infectious Diseases|August 1, 1988
Immunization with rough mutants of Salmonella minnesota: protective activity of IgM and IgG antibody to the R595 (Re chemotype) mutantW R McCabe, A DeMaria, H Berberich, et al.
The Journal of Infectious Diseases|August 1, 1988
Immunization with rough mutants of Salmonella minnesota: initial studies in human subjectsA DeMaria, M A Johns, H Berberich, et al.
Infection|January 1, 1980
In vitro studies of moxalactam (LY127935), a new beta-lactam antibiotic with significant activity against gram-negative bacteriaA DeMaria, S Alvarez, J O Klein, et al.
Pageof 7